Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

VP.91 A preliminary assessment of the psychometric properties of the congenital myotonic dystrophy type 1 rating scale (CDM1-RS) in a phase 2/3 study

Autor: Nikolenko, N., Horrigan, J., Snape, M., Veerapandiyan, A., Evans, S., Lochmüller, H.

Publikováno v: In Neuromuscular Disorders October 2022 32 Supplement 1:S133-S133

E-Learning for Nurses: An Integrative Review.

Autor: Stevens, C. J., Horrigan, J., Koren, I., Heale, R.

Publikováno v: Diversity of Research in Health Journal / Revue de la Diversité de la Recherche en Santé; 2021, Issue 4, p49-64, 16p

Improving Treatment Trial Outcomes for Rett Syndrome

Autor: Neul, JL, Glaze, DG, Percy, AK, Feyma, T, Beisang, A, Dinh, T, Suter, B, Anagnostou, E, Snape, M, Horrigan, J, Jones, NE

Publikováno v: Neul, JL; Glaze, DG; Percy, AK; Feyma, T; Beisang, A; Dinh, T; et al.(2015). Improving Treatment Trial Outcomes for Rett Syndrome. Journal of Child Neurology, 30(13), 1743-1748. doi: 10.1177/0883073815579707. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/8046n7gd

© The Author(s) 2015. Rett syndrome is a genetically based neurodevelopmental disorder. Although the clinical consequences of Rett syndrome are profound and lifelong, currently no approved drug treatments are available specifically targeted to Rett

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::a7657055ab9d760c821c9f03ee1e0e34
http://www.escholarship.org/uc/item/8046n7gd